InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by CARREL MICHAEL H, Chairman & CEO. Officer active across 2 companies, notably AtriCure, Inc.. Cumulatively, 12 filings have been logged. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
067,109 shares0
Common Stock
SEC:0001323885-22-000025:0·
0510 shares0
Common Stock
SEC:0001323885-22-000013:0·
€7,358141 shares@ €52.18530.0005% mcap43.2% of flow
Common Stock
SEC:0001209191-22-000381·
€7,358141 shares@ €52.18530.0005% mcap21.6% of flow
Common Stock
SEC:0001209191-22-000381:0·
010,000 shares0
Common Stock
SEC:0001209191-21-068766·
010,000 shares0
Common Stock
SEC:0001209191-21-068766:0·
0345 shares0
Common Stock
SEC:0001209191-21-064215·
0345 shares0
Common Stock
SEC:0001209191-21-064215:0·
02,261 shares0
Common Stock
SEC:0001562180-21-006775·
02,261 shares0
Common Stock
SEC:0001562180-21-006775:0·
€9,679251 shares@ €38.56020.0007% mcap56.8% of flow
Common Stock
SEC:0001209191-21-044946·
€9,679251 shares@ €38.56020.0007% mcap28.4% of flow
Common Stock
SEC:0001209191-21-044946:0·
12 of 12 declarations
About CARREL MICHAEL H
Michael H. Carrel is President, CEO, and a Director at AtriCure, Inc. and Axonics, Inc. In these roles, he oversees the operations and strategy of the companies, which specialize in medical technologies. Mr. Carrel is responsible for strategic direction and operational management.
